Hypogonadism induced by the administration of anabolic steroids (literature review)
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 3
Abstract
The use of androgens and/or anabolic steroids is common among professional athletes who use them to increase sports performance and bodybuilding, and among young men and adolescents who use them to improve their physical appearance. Some of them develop hypogonadism, since users of androgens and/or anabolic steroids take high doses of drugs, as well as combination and cyclicity of action of several synthetic drugs occur. The pathophysiology of hypogonadism induced by the use of androgenic or anabolic steroids is a combination of disorders at the level of the hypothalamic-pituitary system and direct toxic effects on the testicles. However, such patients rarely seek medical help.
Authors and Affiliations
Ye. V. Luchitsky
Prognostic Value of Proteolysis Indexes in the Formation of Diabetic Retinopathy
The article presents the results of the study on the violations in the proteolysis system of patients with type 2 diabetes mellitus (DM) and diabetic retinopathy (DR). We have evaluated the levels of matrix metalloprotei...
Diagnosis of Diabetic Encephalopathy According to Psychometric Tests in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
55 patients with type 2 diabetes mellitus, nonalcoholic fatty liver disease and encephalopathy were examined, there were 31 women (56.4 %) and 24 men (43.6 %). During the examination we assessed parameters of psychometri...
Ultrasound Densitometry in the Diagnosis of Disorders of Bone Mineral Density in Patients with Thyroid Pathology
The objective of this study was to establish the relationship between the levels of thyroid hormones and characteristics of bone tissue according to radiological and laboratory methods. To assess the influence of thyroid...
Dynamics of fractalkine among Kharkiv residents with different body mass
Background. When developing individual approaches to treating obesity and comorbid diseases, the presence and severity of inflammation in adipose tissue should be taken into account, as it significantly affects its metab...
Practice of Dapagliflozin Application in Patients with Type 2 Diabetes Mellitus
The article presents the results of using new antihyperglycemic drug — a selective inhibitor of the sodium-glucose cotransporter type 2 — dapagliflozin in patients with type 2 diabetes mellitus. The influence of this dru...